____________________________________
From: ju...@bu.edu
To: daa...@aol.com
Sent: 6/3/2013 8:52:41 P.M. Central Daylight Time
Subj: 6-13 SCI Webcast- Advances in Research for Recovery
Don’t forget to register for the June 13th webcast!
Knowledge in Motion
SCI Webcast Series
For individuals living with spinal cord injury,
their caregivers, & healthcare professionals
New Advances in Research
for Recovery after SCI
Presented by
Jeffrey D. Macklis, MD
Harvard Stem Cell Institute
Harvard University
Harvard Medical School
Lisa McKerracher, Ph.D.
BioAxone BioSciences, Inc.
Frank Reynolds
InVivo Therapeutics
Angus McQuilken
Mass. Life Sciences Center
Thursday, June 13, 2013
6:30-8:00 PM Eastern Time
Register to attend _Free Online Webcast and Live Chat_
(http://www.us6.list-manage.com/track/click?u=d2abecee0caf6876e559a54ec&id=d7edd4bc8d&e=905798e
3fb)
(http://www.bu.edu/nerscic/webcast-reg/)
or contact:
Judi Zazula at _judiz@bu.edu_ (mailto:ju...@bu.edu)
617-638-7314
866-607-1804 (toll-free)
Attendees will be able to:
· Understand how the corticospinal nerve injury contributes to
SCI disabilities, and how it might be repaired.
· Understand what new treatment options based on biomaterials
will be available for SCI patients in the near future.
· Learn about the 10-year, $1-billion MA Life Sciences
Initiative and its relevance to the SCI community.
· Learn about the current state of drug development to treat
SCI.
~~~~~
About this month’s speakers and their presentations:
Jeffrey Macklis, MD, Harvard Stem Cell institute, Professor of Stem Cell
and Regenerative Biology at Harvard University, and Professor of Neurology
and Neurosurgery at Harvard Medical School, will discuss the basic neurons
and circuitry that connect the brain to the spinal cord. He will talk
about the kinds of nerve injuries that are central to loss of muscle strength
in SCI. Repair, regeneration, and/or replacement of these neurons by
developmental and stem cell biology might provide useful, real-world therapies
for real people who have lost motor function and bowel/bladder control due
to SCI. Dr. Macklis will highlight a brand new set of approaches that his
lab is using to pursue this goal.
Lisa McKerracher, PhD, Founder, BioAxone Biosciences, will present on
some studies showing that neurons in the spinal cord have the capacity for
regeneration and repair. She will also describe BioAxone’s efforts to develop
a drug called Cethrin™. Cethrin is new therapeutic protein in Phase II
clinical development for the treatment of acute spinal cord injury. It has
shown exceptional promise in promoting motor recovery in quadriplegic
patients. BioAxone Biosciences Inc. is a privately owned American Corporation
with a focus on bringing drugs to market for unmet medical needs.
Angus McQuilken, Vice President for Communications & Marketing at the
Massachusetts Life Sciences Center, will present on the investments being
made by the Massachusetts Life Sciences Center that relate to SCI research and
patient treatment. He will talk about the state’s 10-year, $1-billion
Life Sciences Initiative and its relevance to the SCI community. The
Massachusetts Life Sciences Center is a quasi-public agency of the
Commonwealth of
Massachusetts. The Center’s mission is to create jobs in the life sciences
and support vital scientific research that will improve the human
condition.
Frank Reynolds, Co-Founder, InVivo Therapeutics, will talk about the
relationship of biomaterials to SCI treatments. Whether minimizing secondary
injury in the weeks after the primary injury, or supporting neuroplasticity
during the patient’s recovery, biomaterial based interventions led by
neuroscientists and chemical engineers from MIT are providing new ideas on how
SCI patients will be treated in the near future. InVivo’s technologies
integrate multiple strategies involving biomaterials, FDA approved drugs,
growth factors, and human neural stem cells. Mr. Reynolds will discuss these
technologies as well as their impact on SCI patients.
~~~~~
New England Regional Spinal Cord Injury Center
_www.bu.edu/nerscic_
(http://www.us6.list-manage.com/track/click?u=d2abecee0caf6876e559a54ec&id=e7cd86bfad&e=905798e3fb)
Sent to daa...@aol.com — _why did I get this?_
(http://www.us6.list-manage1.com/about?u=d
2abecee0caf6876e559a54ec&id=f318459fc7&e=905798e3fb&c=442d633474)
_unsubscribe from this list_
(http://www.us6.list-manage2.com/unsubscribe?u=d2abecee0caf6876e559a54ec&id=f318459fc7&e=905798e3fb&c=442d633474)
|
_update subscription preferences_
(http://www.us6.list-manage.com/profile?u=d2abecee0caf6876e559a54ec&id=f318459fc7&e=905798e3fb)
New England Regional Spinal Cord Injury Center · BUMC · 715 Albany Street,
T5W · Boston, MA 02118
(http://www.mailchimp.com/monkey-rewards/?utm_source=freemium_newsletter&utm_medium=email&utm_campaign=monkey_rewards&aid=d2ab
ecee0caf6876e559a54ec&afl=1)
